[HTML][HTML] Inosine pranobex: a key player in the game against a wide range of viral infections and non-infectious diseases

J Sliva, CN Pantzartzi, M Votava - Advances in therapy, 2019 - Springer
Inosine pranobex (IP), commonly known as inosine acedoben dimepranol, isoprinosine and
methisoprinol, has been proven to positively impact the host's immune system, by enhancing …

[HTML][HTML] Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities

K Patil, S Bagade, S Bonde, S Sharma… - Biomedicine & …, 2018 - Elsevier
Tuberculosis is a highly contagious disease spread by Mycobacterium tuberculosis. It is
responsible for highest numbers of death and soon will surpass the deaths caused by HIV …

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv

S Ananthan, ER Faaleolea, RC Goldman, JV Hobrath… - Tuberculosis, 2009 - Elsevier
There is an urgent need for the discovery and development of new antitubercular agents that
target new biochemical pathways and treat drug resistant forms of the disease. One …

Preparation and antitubercular activities in vitro and in vivo of novel Schiff bases of isoniazid

MJ Hearn, MH Cynamon, MF Chen, R Coppins… - European journal of …, 2009 - Elsevier
Structural modification of the frontline antitubercular isonicotinic acid hydrazide (INH)
provides lipophilic adaptations (3–46) of the drug in which the hydrazine moiety of the …

[HTML][HTML] The war against tuberculosis: A review of natural compounds and their derivatives

M Maiolini, S Gause, J Taylor, T Steakin, G Shipp… - Molecules, 2020 - mdpi.com
Tuberculosis (TB), caused by the bacterial organism Mycobacterium tuberculosis, pose a
major threat to public health, especially in middle and low-income countries. Worldwide in …

Innovative therapeutic approaches based on nanotechnology for the treatment and management of tuberculosis

P Kia, U Ruman, AR Pratiwi… - International journal of …, 2023 - Taylor & Francis
Tuberculosis (TB), derived from bacterium named Mycobacterium tuberculosis, has become
one of the worst infectious and contagious illnesses in the world after HIV/AIDS. Long-term …

6-Cyano analogues of bedaquiline as less lipophilic and potentially safer diarylquinolines for tuberculosis

AST Tong, PJ Choi, A Blaser… - ACS medicinal …, 2017 - ACS Publications
Bedaquiline (1) is a new drug for tuberculosis and the first of the diarylquinoline class. It
demonstrates excellent efficacy against TB but induces phospholipidosis at high doses, has …

Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies

RJ Basaraba - Tuberculosis, 2008 - Elsevier
The use of laboratory animals is critical to the discovery and in vivo pre-clinical testing of
new drugs and drug combinations for use in humans. M. tuberculosis infection of mice, rats …

Miscellaneous applications of ferrocene‐based peptides/amides

B Lal, A Badshah, AA Altaf, N Khan… - Applied Organometallic …, 2011 - Wiley Online Library
This article provides a critical review of the different applications of ferrocene‐based
peptides/amides in biological as well as in non‐biological systems. Ferrocene‐based …

Synthesis and Structure− Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6 S)-2-Nitro-6-{[4-(trifluoromethoxy) benzyl] oxy}-6, 7-dihydro-5 H-imidazo …

BD Palmer, AM Thompson, HS Sutherland… - Journal of medicinal …, 2010 - ACS Publications
A series of biphenyl analogues of the new tuberculosis drug PA-824 was prepared, primarily
by coupling the known (6 S)-2-nitro-6, 7-dihydro-5 H-imidazo [2, 1-b][1, 3] oxazin-6-ol with …